Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. D.F. (Douwe) Postma

Publicaties

Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination

Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

Circulating monocytes expressing senescence-associated features are enriched in COVID-19 patients with severe disease

Clinical Impact of Polymerase Chain Reaction-Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study

Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers

External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial

Neurological manifestations of COVID-19 in adults and children

Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial

Lees meer

Pers/media

Na Janssen-vaccinatie mRNA-vaccins meest effectief als booster

Wat is eigenlijk weerstand?